No Data
No Data
glaxosmithkline sues Moderna for infringing its patent rights on the COVID-19 vaccine.
GlaxoSmithKline October 15th | GlaxoSmithKline filed a lawsuit against Moderna in the Federal Court of Delaware on Tuesday, alleging that Moderna's COVID-19 vaccine Spikevax infringed on its patents in mRNA technology. The company filed a similar lawsuit against Pfizer and biontech in the same court in April this year.
Express News | Glaxosmithkline Sues Moderna for U.S. Patent Infringement Over Mrna Technology in Covid-19 Vaccines - Court Filing
Analysts Offer Insights on Healthcare Companies: GlaxoSmithKline (GB:GSK), Gritstone Oncology (GRTS) and Immutep (IMMP)
GSK Says Depemokimab For Chronic Rhinosinusitis Reduces Nasal Polyp Size, Nasal Obstruction Versus Placebo At One Year
GSK Says ANCHOR Trials for Depemokimab Met Primary Endpoints
Stocks to Watch Monday: Tesla, Boeing, Vulcan Materials, GSK -- WSJ